ITGA2 and Hodgkins lymphoma: Our results here demonstrate that the increased expression of ITGA2 in ovarian cancer promoted the malignant biological behavior of tumor cells, which is consistent with findings in studies on pancreatic cancer [29], liver cancer [30], Hodgkin lymphoma [31], and osteosarcoma [32].